Mark Capone

Mark Christopher Capone is the founder of Precision Medicine Advisors LLC, founded in 2020, serving as Chief Executive Officer since its founding.
Current jobs include Independent Director at Mesa Laboratories, Inc. since 2024, Non-Executive Director at Owlstone Medical Ltd., Independent Director at DermTech, Inc. since 2022, and Independent Non-Executive Director at Nephrosant, Inc. since 2021.
Former jobs include President, Chief Executive Officer & Director at Myriad Genetics, Inc. from 2015 to 2020, Sales Director & Plant Manager at Eli Lilly & Co., Director at Myriad RBM, Inc., Director at American Clinical Laboratory Association, Non-Executive Director at Microba Life Sciences Ltd., Non-Executive Director at Abcam Ltd. (United Kingdom) from 2021 to 2023, Chief Operating Officer at Myriad Genetic Laboratories, Inc. from 2006 to 2010, and Trustee at Pioneer Theatre Co. Education includes a graduate degree from Massachusetts Institute of Technology in 1991 and an undergraduate degree from The Pennsylvania State University in 1984.